Skip to main content

Akebia Therapeutics, Inc.

AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001517022

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Akebia Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
143
+25 vs. Q4 2024
Shares held
95.5M
+33.8M (+54.8%) vs. Q4 2024
Total value
$182.7M
+$65.5M (+55.9%) vs. Q4 2024
New holders
30
64 more added
Sold out
5
25 more reduced

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 143 institutions
Q1 2021: 145 institutionsQ2 2021: 139 institutionsQ3 2021: 127 institutionsQ4 2021: 133 institutionsQ1 2022: 124 institutionsQ2 2022: 97 institutionsQ3 2022: 90 institutionsQ4 2022: 75 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 76 institutionsQ4 2023: 87 institutionsQ1 2024: 114 institutionsQ2 2024: 103 institutionsQ3 2024: 114 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 158 institutionsQ3 2025: 177 institutionsQ4 2025: 166 institutionsQ1 2026: 171 institutionsQ2 2026: 170 institutions
Value heldQ1 2025: $182.7M
Q1 2021: $340.3MQ2 2021: $402.4MQ3 2021: $283.7MQ4 2021: $218.7MQ1 2022: $58.3MQ2 2022: $20.2MQ3 2022: $16.5MQ4 2022: $30.2MQ1 2023: $29.1MQ2 2023: $46.0MQ3 2023: $58.0MQ4 2023: $72.7MQ1 2024: $104.3MQ2 2024: $57.4MQ3 2024: $78.4MQ4 2024: $128.9MQ1 2025: $182.7MQ2 2025: $394.1MQ3 2025: $337.7MQ4 2025: $190.4MQ1 2026: $141.4MQ2 2026: $123.2M
Institutions holding AKBA and their total value by quarter
QuarterHoldersValue
Q2 2026170$123.2M
Q1 2026171$141.4M
Q4 2025166$190.4M
Q3 2025177$337.7M
Q2 2025158$394.1M
Q1 2025143$182.7M
Q4 2024121$128.9M
Q3 2024114$78.4M
Q2 2024103$57.4M
Q1 2024114$104.3M
Q4 202387$72.7M
Q3 202376$58.0M
Q2 202379$46.0M
Q1 202365$29.1M
Q4 202275$30.2M
Q3 202290$16.5M
Q2 202297$20.2M
Q1 2022124$58.3M
Q4 2021133$218.7M
Q3 2021127$283.7M
Q2 2021139$402.4M
Q1 2021145$340.3M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding AKBA in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Unified Investment Management17,000$32.6K0.04%+5,500+47.8%Added
David Loasby20,000$31.0K0.00%00.0%Unchanged
Xponance, Inc.15,800$30.3K0.00%+1,511+10.6%Added
California State Teachers Retirement System15,073$28.9K0.00%00.0%Unchanged
Onyx Bridge Wealth Group LLC15,000$28.8K0.00%00.0%Unchanged
Royal Bank of Canada14,332$28.0K0.00%−14,668−50.6%Reduced
Principal Financial Group Inc14,317$27.5K0.00%+2,096+17.2%Added
Advisor Group Holdings, Inc.14,000$26.9K0.00%+7,550+117.1%Added
Independent Wealth Network Inc.13,003$25.0K0.01%00.0%Unchanged
Bank of Montreal12,584$24.2K0.00%+12,584New
Legacy Private Trust Co.12,250$23.5K0.00%00.0%Unchanged
Ameriprise Financial Inc12,052$23.1K0.00%+86+0.7%Added
Sonora Investment Management Group, LLC12,000$23.0K0.00%00.0%Unchanged
James J. Burns & Company, LLC11,748$22.6K0.00%−754−6.0%Reduced
Ethic Inc.11,790$22.5K0.00%+11,790New
Colony Group, LLC11,391$21.2K0.00%+499+4.6%Added
Scientech Research LLC10,510$20.2K0.01%+10,510New
Empirical Asset Management, LLC10,000$19.2K0.01%−3,300−24.8%Reduced
Eagle Wealth Strategies LLC10,000$19.2K0.01%00.0%Unchanged
Cubist Systematic Strategies, LLC7,835$15.0K0.00%+7,835New
SBI Securities Co., Ltd.7,633$14.7K0.00%+4,500+143.6%Added
Amalgamated Bank7,197$14.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)6,287$12.1K0.00%−1,578−20.1%Reduced
Ameliora Wealth Management Ltd.5,615$10.8K0.00%00.0%Unchanged
CWM, LLC3,533$7.00K0.00%+1,989+128.8%Added
GPS Wealth Strategies Group, LLC3,625$6.96K0.00%00.0%Unchanged
Sterling Capital Management LLC3,410$6.55K0.00%−2,654−43.8%Reduced
Fifth Third Bancorp3,300$6.34K0.00%00.0%Unchanged
Point72 Asset Management, L.P.2,190$4.21K0.00%+2,190New
Activest Wealth Management2,000$3.84K0.00%00.0%Unchanged
Jones Financial Companies LLLP1,000$1.91K0.00%00.0%Unchanged
Allworth Financial LP748$1.71K0.00%00.0%Unchanged
Truvestments Capital LLC756$1.45K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC666$1.28K0.00%+66+11.0%Added
Capital Advisors, Ltd. LLC320$1.00K0.00%00.0%Unchanged
Farther Finance Advisors, LLC412$7870.00%+412New
TD Waterhouse Canada Inc.327$6210.00%−98,291−99.7%Reduced
EverSource Wealth Advisors, LLC243$4670.00%+229+1,635.7%Added
Federation des caisses Desjardins du Quebec150$2880.00%00.0%Unchanged
Rothschild Investment LLC105$2020.00%+105New
True Wealth Design, LLC37$720.00%+37New
Northwestern Mutual Wealth Management Co5$100.00%+5New
Nuveen, LLC350,413––+350,413New
National Asset Management, Inc.0$00.00%−43,360−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−40,826−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−24,998−100.0%Sold out
Atom Investors LP0$00.00%−12,903−100.0%Sold out
RB Capital Management, LLC0$00.00%−10,000−100.0%Sold out
Satter Management Co., L.P.––––Not filed
Nuveen Asset Management, LLC––––Not filed
AlphaMark Advisors, LLC––––Not filed